Exec VP and CFO of Varian Medical Systems, Inc. (VAR) Elisha W Finney sells 7,524 shares of VAR on 12/20/2012 at an average price of $71.5 a share.

Varian Medical Systems, Inc. has a market cap of $7.82 billion; its shares were traded at around $70.94 with a P/E ratio of 18.7 and P/S ratio of 2.8. Varian Medical Systems, Inc. had an annual average earning growth of 16.2% over the past 10 years. GuruFocus rated Varian Medical Systems, Inc. the business predictability rank of 5-star.

CEO Recent Trades:

President and CEO Dow R Wilson sold 26,000 shares of VAR stock on 11/02/2012 at the average price of 70. Dow R Wilson owns at least 37,821 shares after this. The price of the stock has increased by 1.34% since.

President and CEO Dow R Wilson sold 10,000 shares of VAR stock on 11/01/2012 at the average price of 67.02. Dow R Wilson owns at least 37,821 shares after this. The price of the stock has increased by 5.85% since.

CFO Recent Trades:

Exec VP and CFO Elisha W Finney sold 7,524 shares of VAR stock on 12/20/2012 at the average price of 71.5. Elisha W Finney owns at least 29,025 shares after this. The price of the stock has decreased by 0.78% since.

Exec VP and CFO Elisha W Finney sold 8,000 shares of VAR stock on 11/02/2012 at the average price of 69.95. Elisha W Finney owns at least 36,561 shares after this. The price of the stock has increased by 1.42% since.

Exec VP and CFO Elisha W Finney sold 41,360 shares of VAR stock on 11/01/2012 at the average price of 67.06. Elisha W Finney owns at least 44,561 shares after this. The price of the stock has increased by 5.79% since.

Exec VP and CFO Elisha W Finney sold 4,000 shares of VAR stock on 10/01/2012 at the average price of 60.81. Elisha W Finney owns at least 55,047 shares after this. The price of the stock has increased by 16.66% since.

Exec VP and CFO Elisha W Finney sold 4,000 shares of VAR stock on 09/04/2012 at the average price of 60.82. Elisha W Finney owns at least 55,047 shares after this. The price of the stock has increased by 16.64% since.

Directors and Officers Recent Trades:

SVP, Gen Counsel and Secretary John W Kuo sold 1,111 shares of VAR stock on 12/14/2012 at the average price of 71.23. John W Kuo owns at least 10,796 shares after this. The price of the stock has decreased by 0.41% since.

SVP and Pres. Oncology Sys. Kolleen T Kennedy sold 954 shares of VAR stock on 12/14/2012 at the average price of 71.32. Kolleen T Kennedy owns at least 11,927 shares after this. The price of the stock has decreased by 0.53% since.

SVP and Pres. Oncology Sys. Kolleen T Kennedy sold 640 shares of VAR stock on 12/11/2012 at the average price of 72.01. Kolleen T Kennedy owns at least 11,927 shares after this. The price of the stock has decreased by 1.49% since.

Corp SVP; Pres. X-Ray Products Robert H Kluge sold 40,500 shares of VAR stock on 12/11/2012 at the average price of 72. Robert H Kluge owns at least 28,211 shares after this. The price of the stock has decreased by 1.47% since.

SVP, Gen Counsel and Secretary John W Kuo sold 7,872 shares of VAR stock on 12/11/2012 at the average price of 72. John W Kuo owns at least 10,796 shares after this. The price of the stock has decreased by 1.47% since.

Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.
Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.